Activation of the EBV/C3d Receptor (CR2, CD21) on Human B Lymphocyte Surface Triggers Tyrosine Phosphorylation of the 95-kDa Nucleolin and Its Interaction with Phosphatidylinositol 3 Kinase1

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Immunology

• Publication date

  2001-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.166.5.3167PMID 11207269
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CD19-dependent Activation of Akt Kinase in B-lymphocytes*

  2001cited by this paper
• Immunomodulatory functions of murine CR1/2.

  2000cited by this paper
• Signaling through the EBV/C3d receptor (CR2, CD21) in human B lymphocytes: activation of phosphatidylinositol 3-kinase via a CD19-independent pathway.

  1999cited by this paper
• Molecular dissection of nucleolin's role in growth and cell proliferation: new insights

  1999cited by this paper
• Cellular Adhesion Mediated by Factor J, a Complement Inhibitor

  1998cited by this paper
• Pleckstrin homology domains.

  1998cited by this paper
• Mechanisms and consequences of activation of protein kinase B/Akt.

  1998cited by this paper
• Protection of CD95‐mediated apoptosis by activation of phosphatidylinositide 3‐kinase and protein kinase B

  1998cited by this paper
• Nucleolin is one component of the B cell-specific transcription factor and switch region binding protein, LR1.

  1997cited by this paper
• Nucleocytoplasmic transport: signals, mechanisms and regulation

  1997cited by this paper
• Nucleolin is one component of the B cell-specific transcription factor and switch region binding protein , LR 1 ( Ig y rDNA y recombination )

  1997cited by this paper
• Epstein‐Barr virus/C3d receptor (CR2, CD21) activated by its extracellular ligands regulates pp105 phosphorylation through two distinct pathways

  1995cited by this paper
• Binding sites of the Epstein-Barr virus and C3d receptor (CR2, CD21) for its three intracellular ligands, the p53 anti-oncoprotein, the p68 calcium binding protein and the nuclear p120 ribonucleoprotein.

  1995cited by this paper
• Pep34, a synthetic peptide whose sequence corresponds to the intracytoplasmic domain of the Epstein-Barr virus receptor (CR2, CD21), regulates human B lymphocyte proliferation triggered through CR2.

  1995cited by this paper
• Activation of phosphatidylinositol-3' kinase by Src-family kinase SH3 binding to the p85 subunit.

  1994cited by this paper
• Signal Transduction Through the Epstein-Barr Virus Receptor in Human B Lymphocytes

  1993cited by this paper
• CD19 of B cells as a surrogate kinase insert region to bind phosphatidylinositol 3-kinase.

  1993cited by this paper
• Identification of a ten-amino acid proline-rich SH3 binding site.

  1993cited by this paper
• Functional dissection of the CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytes

  1993cited by this paper
• A 16 amino acid synthetic peptide derived from human C3d triggers proliferation and specific tyrosine phosphorylation of transformed CR2-positive human lymphocytes and of normal resting B lymphocytes.

  1992cited by this paper
• Interaction of the p85 subunit of PI 3‐kinase and its N‐terminal SH2 domain with a PDGF receptor phosphorylation site: structural features and analysis of conformational changes.

  1992cited by this paper
• CD21 is a ligand for CD23 and regulates IgE production

  1992cited by this paper
• EBV/C3d receptor (CR2) interacts by its intracytoplasmic carboxy-terminal domain and two distinct binding sites with the p53 anti-oncoprotein and the p68 calcium-binding protein.

  1992cited by this paper
• The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules.

  1992cited by this paper
• A 16 amino acid synthetic peptide derived from human C3d triggers proliferation and specific tyrosine phosphoryiation of CR2-positive human lymphocytes and of normal resting B lymphocytes

  1992cited by this paper
• Determination of the structural basis for selective binding of Epstein- Barr virus to human complement receptor type 2

  1991cited by this paper
• Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19

  1991cited by this paper
• Intracellular interaction of EBV/C3d receptor (CR2) with p68, a calcium-binding protein present in normal but not in transformed B lymphocytes.

  1991cited by this paper
• Analysis of Epstein-Barr virus-binding sites on complement receptor 2 (CR2/CD21) using human-mouse chimeras and peptides. At least two distinct sites are necessary for ligand-receptor interaction.

  1991cited by this paper
• Structural requirements for C3d,g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization, and viral infection.

  1990cited by this paper
• Identification of major nucleolar proteins as candidate mitotic substrates of cdc2 kinase.

  1990cited by this paper
• Epstein-Barr virus/complement fragment C3d receptor (CR2) reacts with p53, a cellular antioncogene-encoded membrane phosphoprotein: detection by polyclonal anti-idiotypic anti-CR2 antibodies.

  1989cited by this paper
• Protein kinase NII and the regulation of rDNA transcription in mammalian cells.

  1989cited by this paper
• C3 synthetic peptides support growth of human CR2-positive lymphoblastoid B cells.

  1989cited by this paper
• Enhancement of Epstein-Barr virus/C3d receptor (EBV/C3dR or CR2) and nuclear p120 ribonucleoprotein phosphorylation by specific EBV/C3dR ligands in subcellular fractions of the human B lymphoma cell line, Raji.

  1989cited by this paper
• Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes.

  1988cited by this paper
• Monoclonal and anti-idiotypic anti-EBV/C3d receptor antibodies detect two binding sites, one for EBV and one for C3d on glycoprotein 140, the EBV/C3dR, expressed on human B lymphocytes.

  1988cited by this paper
• Structure of the human B lymphocyte receptor for C3d and the Epstein- Barr virus and relatedness to other members of the family of C3/C4 binding proteins [published erratum appears in J Exp Med 1988 Nov 1;168(5):1953-4]

  1988cited by this paper
• Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis.

  1987cited by this paper
• gp140, the EBV/C3d receptor (CR2) of human B lymphocytes, is involved in cell‐free phosphorylation of p120, a nuclear ribonucleoprotein

  1987cited by this paper
• [C3 stimulates the proliferation of human pre-B Raji cells].

  1987cited by this paper
• Molecular cloning of the cDNA encoding the Epstein-Barr virus/C3d receptor (complement receptor type 2) of human B lymphocytes.

  1987cited by this paper
• Le C3 stimule la prolifration des cellules humaines pr-B de la ligne Raji

  1987cited by this paper
• Phosphorylation of nucleolin by a nucleolar type NII protein kinase.

  1987cited by this paper
• Activation of B lymphocytes by Epstein‐Barr virus/CR2 receptor interaction

  1987cited by this paper
• gp 140, the C3d/EBV receptor (CR2), is phosphorylated upon in vitro activation of human peripheral B lymphocytes

  1986cited by this paper
• Autoantibodies against gp140, the Epstein‐Barr virus and C3d receptor in sera from rheumatoid arthritis patients

  1986cited by this paper
• Tissue-specific phosphorylation of complement receptors CR1 and CR2

  1986cited by this paper
• Binding of monoclonal antibody to the Epstein Barr virus (EBV)/CR2 receptor induces activation and differentiation of human B lymphocytes.

  1985cited by this paper
• Growth control of activated, synchronized murine B cells by the C3d fragment of human complement

  1985cited by this paper
• gp140, the C3d receptor of human B lymphocytes, is also the Epstein-Barr virus receptor.

  1985cited by this paper
• Mapping of the C3d receptor (CR2)-binding site and a neoantigenic site in the C3d domain of the third component of complement.

  1985cited by this paper
• Enhancement of human B cell proliferation by an antibody to the C3d receptor, the gp 140 molecule

  1985cited by this paper
• gp140, a C3b‐binding membrane component of lymphocytes, is the B cell C3dg/C3d receptor (CR2) and is distinct from the neutrophil C3dg receptor (CR4)

  1985cited by this paper
• Interrelations between the maturation of a 100 kDa nucleolar protein and pre rRNA synthesis in CHO cells.

  1984cited by this paper
• Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes.

  1984cited by this paper
• Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2.

  1984cited by this paper
• Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody

  1983cited by this paper
• Isolation and characterization of a C3b receptor‐like molecule from membranes of a human B lymphoblastoid cell line (Raji)

  1981cited by this paper

• Ubiquitination-dependent degradation of nucleolin mediated by porcine circovirus type 3 capsid protein

  2023cites this paper
• Myogenetic Oligodeoxynucleotide (myoDN) Recovers the Differentiation of Skeletal Muscle Myoblasts Deteriorated by Diabetes Mellitus

  2021cites this paper
• Identification of the Myogenetic Oligodeoxynucleotides (myoDNs) That Promote Differentiation of Skeletal Muscle Myoblasts by Targeting Nucleolin

  2020cites this paper
• New perspectives of physiological and pathological functions of nucleolin (NCL)

  2017cites this paper
• Receptor protein tyrosine phosphatase beta/zeta is a functional binding partner for vascular endothelial growth factor

  2015cites this paper
• Tyrosine phosphorylation of 3BP2 is indispensable for the interaction with VAV3 in chicken DT40 cells.

  2014cites this paper
• Host-Bacteria Interactions

  2014cites this paper
• Cell surface nucleolin as a target for anti-cancer therapies.

  2014cites this paper
• Detection of the interaction between host and bacterial proteins: eukaryotic nucleolin interacts with Francisella elongation factor Tu.

  2014cites this paper
• AU-rich RNA binding proteins in hematopoiesis and leukemogenesis.

  2011cites this paper
• Epstein-Barr Virus Infection of Polarized Epithelial Cells via the Basolateral Surface by Memory B Cell-Mediated Transfer Infection

  2011cites this paper
• Virulence-related Mycobacterium avium subsp hominissuis MAV_2928 gene is associated with vacuole remodeling in macrophages

  2010cites this paper
• Novel roles for murine complement receptors type 1 and 2 I. Regulation of B cell survival and proliferation by CR1/2.

  2008cites this paper
• A novel receptor – ligand pathway for entry of Francisella tularensis in monocyte-like THP-1 cells: interaction between surface nucleolin and bacterial elongation factor Tu

  2008cites this paper
• Cell-surface nucleolin is a signal transducing P-selectin binding protein for human colon carcinoma cells.

  2008cites this paper
• Mechanistic Studies of Oligonucleotide Aptamers With Potent Antiproliferative and Pro-Apoptotic Activity Against Prostate Cancer Cells

  2007cites this paper
• Regulation of class IA phosphoinositide 3-kinase signalling enzymes by post-translational modifications, protein interactions and absolute protein expression levels.

  2006cites this paper
• AGRO100 inhibits activation of nuclear factor-kappaB (NF-kappaB) by forming a complex with NF-kappaB essential modulator (NEMO) and nucleolin.

  2006cites this paper
• Up-regulation of the KLF2 Transcription Factor by Fluid Shear Stress Requires Nucleolin*

  2006cites this paper
• Activation of Epstein-Barr virus/C3d receptor (gp140, CR2, CD21) on human B lymphoma cell surface triggers Cbl tyrosine phosphorylation, its association with p85 subunit, Crk-L and Syk and its dissociation with Vav.

  2006cites this paper
• AGRO100 inhibits activation of nuclear factor-κB (NF-κB) by forming a complex with NF-κB essential modulator (NEMO) and nucleolin

  2006cites this paper
• Functional analysis of the cytoplasmic domain of complement receptor type II (CR2/CD21)

  2006cites this paper
• CD 19 function in central and peripheral B-cell development

  2005cites this paper
• Complement receptors and B lymphocytes.

  2004cites this paper
• Autoimmunity, complement activation, tissue injury and reciprocal effects.

  2004cites this paper
• Cell signals transduced by complement.

  2004cites this paper
• Role of CD21 antigen in diffuse large B‐cell lymphoma and its clinical significance

  2004cites this paper
• Coordination of Adaptive Immune Responses by C3

  2004cites this paper
• Activation of Epstein‐Barr virus/C3d receptor (gp140, CR2, CD21) on human cell surface triggers pp60src and Akt‐GSK3 activities upstream and downstream to PI 3‐kinase, respectively

  2003cites this paper
• Lytic Viral Replication as a Contributor to theDetection of Epstein-Barr Virus in BreastCancer

  2003cites this paper
• Antigen receptor triggered upregulation of CD86 and CD80 in human B cells: augmenting role of the CD21/CD19 co-stimulatory complex and IL-4.

  2002cites this paper